Medicamen Biotech (BOM:531146) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531146 Medicamen Biotech Ltd BOM:531146
67 GF Score
Price ₹343.50
GF Value ₹489.99
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Medicamen Biotech Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:531146
67GF Score
Medicamen Biotech Ltd BOM:531146
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medicamen Biotech (BOM:531146) Overvalued in 2026?

Based on GuruFocus' analysis, Medicamen Biotech stock appears to be undervalued. The current stock price of ₹343.50 is trading 29.9% below its estimated GF Value™ of ₹489.99. GuruFocus considers Medicamen Biotech to be Significantly Undervalued.

Key valuation signals for BOM:531146:

  • Short Ratio:
  • GF Value™: ₹489.99 vs. price of ₹343.50 (29.9% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the BOM:531146 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicamen Biotech Business Description

Other Exchanges MEDICAMEQ:India
Address 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. It generates revenue from the sale of pharmaceutical products.
67GF Score

Get the complete analysis for BOM:531146

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹343.50
Price
₹489.99
GF Value